资讯
A 19-year-old woman with a history of depression and anxiety symptoms was admitted to the hospital because of seizure, ...
The company plans to direct resources away from a drug developed by subsidiary Recognify Life Sciences and toward Atai’s ...
4 天
Clinical Trials Arena on MSNRecognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goalThe trial failed to achieve statistical significance in its goal of improved MCCB neurocognitive composite scores.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果